| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $114.2M | $15.6M | $16.4M |
| YoY Revenue Growth % | +631.8% | -4.7% | — |
| Gross Profit | -$143.8M | -$83.3M | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$259.3M | -$175.2M | -$152.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$969.6M | -$685.9M | -$229.5M |
| EBITDA (Normalized) | -$216.2M | -$148.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$211.2M | -$153.9M | -$145.0M |
| Capital Expenditures (CapEx) | $53.8M | $33.2M | — |
| Free Cash Flow (FCF) | -$265.0M | -$187.1M | -$145.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $568.0M | $74.3M | — |
| Total Debt (Short + Long Term) | $812.9M | $314.9M | — |
| Total Stockholders' Equity | -$2.24B | -$1.07B | — |